Litigation Details for Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-03-22 |
Court | District Court, D. Delaware | Date Terminated | 2019-08-29 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,992,218; 9,399,012; 9,610,265; 9,987,238 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd.
Details for Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-03-22 | 1 | Complaint | . 6,992,218 (the “’218 patent”) (collectively, the “Patents-in-Suit”). Case 1:19-cv-00552-LPS Document…of U.S. Patent No. 9,399,012 (the “’012 patent”), U.S. Patent No. 9,610,265 (the “’265 patent”), and … U.S. Patent No. 9,987,238 (the “’238 patent”), and is the exclusive sub-licensee of U.S. Patent No. … action for infringement of the Patents-in-Suit pursuant to the Patent Laws of the United States, 35 …the ’218 Patent. Altan’s submission of the Altan NDA constitutes infringement of the Patents-in-Suit | External link to document |
2019-08-29 | 15 | Judgment - Consent | .S . Patent Nos. 9,610,265, 9,399,012, 9,987,238, and 6,992,21 8 (the "Plaintiffs Patents"… Plaintiffs Patents was a technical act of infringement of the Plaintiffs Patents under 35 U.S.C…OF PERMANENT INJUNCTION This action for patent infringement has been brought by Plaintiffs, Mallinckrodt…charged Altan with infringement of the Plaintiffs Patents in connection with Altan' s submission… restrained from infringing the Plaintiffs Patents by making, using selling, offering for | External link to document |
2019-03-22 | 4 | Patent/Trademark Report to Commissioner of Patents | ; 9,610,265 B2; 9,987,238 B2; 6,992,218 B2. (ceg) (Entered: 03/22/2019) 22 March 2019 PACER Document… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2; …2019 29 August 2019 1:19-cv-00552 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |